| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.9M | -10.6% |
| Cost of Revenue | $1.3M | -79.6% |
| Gross Profit | $5.6M | +294.1% |
| R&D Expense | $2.5M | +4.9% |
| SG&A Expense | $7.1M | -9.2% |
| Operating Income | -$4.0M | +54.6% |
| Pre-tax Income | -$4.3M | +50.0% |
| Income Tax | -$23K | +82.8% |
| Net Income | -$4.3M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $438K | -14.4% |
| Accounts Receivable | $718K | -40.2% |
| Inventory | $378K | -15.1% |
| Current Assets | $1.9M | -28.0% |
| Total Assets | $8.6M | +90.7% |
| Current Liabilities | $4.6M | +41.7% |
| Long-term Debt | $45K | -76.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.9M | +23.2% |
| Capital Expenditures | $13K | +1204.7% |
| Investing Cash Flow | -$13K | -1204.7% |
| Financing Cash Flow | $2.8M | +97.2% |
| Free Cash Flow | -$2.9M | +22.9% |
| +49.5% |
| EPS (Basic) | -$2.09 | +86.3% |
| Total Liabilities |
| $4.8M |
| +40.3% |
| Stockholders' Equity | $3.8M | +254.7% |